11 Oct 2018 11:00
JPMORGAN EUROPEAN INVESTMENT TRUST PLC (the 'Company') |
|
Legal Entity Identifier: 549300D8SPJFHBDGXS57 |
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 30 September 2018 |
|
Growth Portfolio * |
|
Nestle | 5.0% |
Novartis | 4.1% |
Roche Holdings | 3.7% |
JPMorgan European Smaller Companies Trust | 3.6% |
Allianz | 2.8% |
Sanofi-Aventis | 1.8% |
UPM-Kymmene | 1.8% |
Repsol | 1.7% |
Novo Nordisk | 1.7% |
Ahold Delhaize | 1.7% |
Total | 27.9% |
Income Portfolio * |
|
Novartis | 3.0% |
Total | 2.7% |
Roche Holdings | 2.7% |
Allianz | 1.8% |
Sanofi-Aventis | 1.7% |
Unilever | 1.4% |
Bayer | 1.4% |
Novo Nordisk | 1.4% |
BASF | 1.4% |
Daimler | 1.1% |
Total | 18.6% |
* Based on invested portfolio |
|
Name of contact and telephone number for queries: |
|
Debbie Sarfas 0044 207 742 3449 |
|
Name of authorised company official responsible for making this notification: |
|
Paul Winship 0044 207 742 9815 - Company Secretary |
|
Date: 11 October 2018 |
|
|
|